Results 161 to 170 of about 56,599 (248)

Vancomycin-induced linear IgA bullous dermatosis mimicking Stevens-Johnson syndrome/toxic epidermal necrolysis treated with etanercept. [PDF]

JAAD Case Rep
Alanazi R, Aldahash R, Alanazi SK, Almasoud SH, Alumair NA, Alghamdi W, Alhumidi A.   +6 more
europepmc   +1 more source

Effective Management of Recalcitrant Hailey–Hailey Disease With Risankizumab

International Journal of Dermatology, Volume 65, Issue 7, Page 1457-1459, July 2026.
Joy Justice, Adriana Della Porta, Eva Niklinska, Jami L. Miller   +3 more
wiley   +1 more source

Pulmonary Rheumatoid Nodules: A Case Report

Respirology Case Reports, Volume 14, Issue 6, June 2026.
PRNs, a rare extra‐articular manifestation of RA, should be distinguished from infections and malignancies. High‐resolution chest CT and biopsy help in the diagnosis. ABSTRACT Rheumatoid arthritis (RA) is an autoimmune disorder primarily targeting joints, with the lungs often being the most affected organ outside the joints.
Mingli Yuan, Wen Yin, Liangchao Wang, Shenglan Ye   +3 more
wiley   +1 more source

Efficacy, safety, and patient-reported outcomes of combination etanercept andsulfasalazine versus etanercept alone in patients with rheumatoid arthritis: adouble-blind randomized two-year study.

, 2009
OBJECTIVE: To determine the efficacy and safety of etanercept and etanercept plus sulfasalazine versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.
KVIEN TK, FATENEJAD S., WAJDULA J, COMBE B, KHANDKER R, GAUBITZ M, FIOCCO, UGO, SINGH A, PAVELKA K, SAMBROOK PN, GEUSENS PP, CODREANU C, SMOLEN JS   +12 more
core  

Biological Therapy for Moderate-to-Severe Psoriasis: A 5-Year Analysis of Patients from Lithuania. [PDF]

Medicina (Kaunas)
Indrisiunaite E, Jonaityte IR, Karmaziene T, Raudonis T.   +3 more
europepmc   +1 more source

Association of Body Mass Index with SARS‐CoV‐2 Infection in Inflammatory Arthritis Patients Receiving Biologic Therapy: Singapore National Biologics Register Findings

International Journal of Rheumatic Diseases, Volume 29, Issue 6, June 2026.
ABSTRACT Purpose To determine the association of body mass index (BMI) with incident COVID‐19 infection in patients with inflammatory arthritis (IA) using biologic disease‐modifying anti‐rheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) and to describe characteristics of patients with severe COVID‐19 infection. Methods This prospective
Preeti Dhanasekaran, Siaw Ing Yeo, Yi Xin Ng, Rosa Lim, Stephanie Wong, Stanley Angkodjojo, Andrew Yu Keat Khor, Li Wearn Koh, Manjari Lahiri, Margaret Ma   +9 more
wiley   +1 more source

Effects of sialylated oligosaccharides on the N- and O-glycosylation of etanercept in recombinant CHO cells. [PDF]

Appl Microbiol Biotechnol
Kim TH, Lee HM, Ryu SH, Kim HS, Koo SJ, Kang MJ, You J, Kim YG.   +7 more
europepmc   +1 more source

Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1206-1209, June 2026.
Stephen J. Balevic, Daniel Gonzalez, Bernd Meibohm   +2 more
wiley   +1 more source

Reactive Infectious Mucocutaneous Eruption (RIME): An Australian Case Series

Australasian Journal of Dermatology, Volume 67, Issue 4, Page 241-246, June 2026.
ABSTRACT Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative.
Hamish Moore, Emma Ryan, Annabel Stevenson   +2 more
wiley   +1 more source

Computational modeling-directed combination treatment with etanercept and mifepristone mitigates neuroinflammation in a mouse model of Gulf War Illness. [PDF]

PLoS One
Kelly KA, Felton CM, Billig BK, Yilmaz AA, O'Callaghan JP, Craddock TJA, Broderick G, Klimas N, Michalovicz LT.   +8 more
europepmc   +1 more source